Correction to: Cancer Immunology, Immunotherapy (2025) 74:129 10.1007/s00262-024-03885-1
In the original version of this article, in Table 1 and Supplementary File 3, the T stage category incorrectly included Tx in the T0–2 range, and the N stage mistakenly included Nx in the N0–2 range and incorrect values in the "Liver Metastasis" row. “Smoke” and “Alcohol” variables were misrepresented and full term "Epstein–Barr virus (EBV)" has been included instead of abbreviation (EBV).
Table 1.
Characteristics of patients
| Characteristic | Patients, no. (%) (N = 153) |
|---|---|
| Age (mean (SD)) | 47.6 (9.8) |
| Gender | |
| Male | 125 (81.7) |
| Female | 28 (18.3) |
| ECOG PSa | |
| 0 | 59 (38.6) |
| 1 | 94 (61.4) |
| T stage | |
| T0–2 | 52 (34.0) |
| T3–4 | 50 (32.7) |
| Tx | 51 (33.3) |
| N stage | |
| N0–2 | 84 (54.9) |
| N3 | 26 (17.0) |
| Nx | 43 (28.1) |
| Liver metastasis | |
| Yes | 71 (46.4) |
| Nob | 82 (53.6) |
| Smoke | |
| Yes | 55 (35.9) |
| No | 98 (64.1) |
| Alcohol | |
| Yes | 42 (27.5) |
| No | 111 (72.5) |
| Lactate dehydrogenase U/L (median [IQR]) | 232.0 [176.0, 403.0] |
| EBV DNAc copies/mL (median [IQR]) | 1865.0 [421.5, 12,275.0] |
| Body mass index (median [IQ R]) | 21.6 [19.1, 23.5] |
aECOG PS Eastern Cooperative Oncology Group Performance Status
bThis includes both patients with no metastasis and those with metastasis to other sites but without liver involvement
cEBV Epstein–Barr virus
The table 1, which previously appeared as but should have appeared as
Table 1.
Characteristics of patients
| Characteristic | Patients, No. (%) (N = 153) |
|---|---|
| Age (mean (SD)) | 47.6 (9.8) |
| Gender | |
| Male | 125 (81.7) |
| Female | 28 (18.3) |
| ECOG PSa | |
| 0 | 59 (38.6) |
| 1 | 94 (61.4) |
| T Stage | |
| T0-2 | 103 (67.3) |
| T3-4 | 50 (32.7) |
| N stage | |
| N0-2 | 127 (83.0) |
| N3 | 26 (17.0) |
| Liver metastasis | |
| Yesb | 59 (38.6) |
| No | 94 (61.4) |
| Smoke | |
| Yes | 98 (64.1) |
| No | 55 (35.9) |
| Alcohol | |
| Yes | 111 (72.5) |
| No | 42 (27.5) |
| Lactate dehydrogenase U/L (median [IQR]) | 232.0 [176.0, 403.0] |
| EBV DNA copies/mL (median [IQR]) | 1865.0 [421.5, 12275.0] |
| Body mass index (median [IQR]) | 21.6 [19.1, 23.5] |
a: ECOG PS, Eastern Cooperative Oncology Group Performance Status
b: This includes both patients with no metastasis and those with metastasis to other sites but without liver involvement
The wrong Supplementary file 3 has now been replaced with the correct file.
Supplementary Information
Below is the link to the electronic supplementary material.
Footnotes
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Contributor Information
Ye Chen, Email: 463527617@qq.com.
Xingchen Peng, Email: pxx2014@163.com.
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.